PSI Names Andrea Cracraft Director Clinical Operations North America

barbara.lempert Zug, Switzerland, June 19, 2013 (BUSINESS WIRE) –PSI CRO, a full-service contract research organization, announced today the appointment of Andrea Cracraft as Director, ...

Kineta and Rosa form strategic alliance for next stage of clinical development of lead drug candidate Shk-186

barbara.lempert SEATTLE, WA, June 14, 2013 – Kineta, Inc. a biotechnology company focused on the development of novel modulating drugs for critical disease areas, announced today ...

EU grants EUR 6m to the clinical development of Athera´s cardiovascular disease antibody therapy

barbara.lempert STOCKHOLM, SWEDEN – June 17, 2013. Athera Biotechnologies AB today announced that future development costs of its fully human antibody PC-mAb up until proof-of-concept ...

Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215

barbara.lempert Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215 for the Treatment of Multiple Myeloma — ...

TG Therapeutics, Inc. Announces Clinical and Pre-Clinical Poster Presentations for TG-1101 and TGR-1202

barbara.lempert TG Therapeutics, Inc. Announces Clinical and Pre-Clinical Poster Presentations for TG-1101 and TGR-1202 at the European Hematology Association (EHA) Meeting in Stockholm, ...

Nanobiotix receives approval from ANSM to start new Clinical Trial with Lead Product NBTXR3

barbara.lempert Second indication for NanoXray product in Head and Neck cancer patients Paris, France, June 13, 2013 – NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine ...

Why Do Most Americans Avoid Clinical Trials?

esilverman Despite increasing clamoring for new treatments, drugmakers regularly complain that enticing people in the US to enroll in clinical trials is not particularly easy. ...

CTI Clinical Trial and Consulting Services Announces Collaboration

barbara.lempert with Galectin Therapeutics on Novel Phase I NASH Clinical Trial   [Cincinnati, OH ~ June 6, 2013]  CTI Clinical Trial and Consulting Services (CTI) announces its ...

Abbott Initiates Randomized Clinical Trial in Japan

barbara.lempert Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold – Trial to Study the Innovative “Dissolving” ...

SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing

barbara.lempert SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury MOUNTAIN ...

Another Bill To Require Clinical Trial Disclosures, Or Else

esilverman File this under ‘try and try again.’ A US Congressman has, once again, introduced legislation that would require study results to be reported to ClinicalTrials.gov ...

PCI Strengthens European Clinical Trials Leadership with Senior Appointment

barbara.lempert Confirms commitment to growing Clinical Trials business Powys, UK (6 June 2013) – PCI, a global supplier of pharmaceutical commercial packaging solutions and clinical ...
Page 5 of 6« First...23456
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS